Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita

The purpose of this clinical trial is to compare the efficacy and safety of emodepside with the standard treatment, albendazole, in adolescents (12 years and older) and adults infected with Trichuris incognita.

Participants needed: 100
Trial details
Phase: Phase 2Age: 12+Biological sex: AllType: InterventionalSponsor: Jennifer KeiserUpdated: May 8, 2026
Eligibility criteria

Aged 12 years and above. [+4]

Presence or signs of major systemic illnesses, e.g. body temperature ≥ 38 °C, se... [+8]

Status: Not yet recruiting

Efficacy and Safety of Ascending Doses of Arpraziquantel in Children Infected With Opisthorchis Viverrini

This study aims to assess the efficacy, safety and acceptability of ascending doses of arpraziquantel in children infected with Opisthorchis viverrini. The primary objective is to determine the dose-response relationship in terms of cure rate. This study will involve children aged 6-7 years, since O. viverrini infections often occur in pre-school and school-aged children, and this group is largely left untreated in current public health programs.

Participants needed: 125
Trial details
Phase: Phase 2Age: 6-7Biological sex: AllType: InterventionalSponsor: Jennifer KeiserUpdated: Mar 20, 2026Locations: 1
Eligibility criteria

Aged 6 to 7 years (i.e., 72 to 95 months). [+4]

Presence or signs of major systemic illness, e.g. severe anaemia (haemoglobin le... [+7]